Acura Pharmaceuticals Profile

USD 0.0299  4.82%

Sale by Claudius Llc of 2195734 shares of Acura Pharmaceuticals

Acura Pharmaceuticals Inc insider trading alert for sale of common stock by Claudius Llc, the corporate stakeholder, on January 19, 2018. This event was filed by Acura Pharmaceuticals Inc with SEC on 2018-01-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Acura Pharmaceuticals Summary

Acura Pharmaceuticals Inc (ACUR) is traded on OTC Market in USA. It is located in ILLINOIS, U.S.A and employs 15 people. Acura Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 12.89 M. Acura Pharmaceuticals Inc conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 20.8 M outstanding shares of which 89.85 K shares are presently shorted by private and institutional investors with about 0.73 trading days to cover. ACURA PHARMACEUTI currently holds about 4.79 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Acura Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Essex Woodlands Health Ventures IncCommon Shares2 M783 K
Essex Woodlands Health Ventures IncCommon Shares2 M880 K
Simplex Trading LlcPut Options86.037 K
Simplex Trading LlcCall Options69.01000
View Acura Pharmaceuticals Diagnostics

Selected Acura Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Acura Pharmaceuticals Against Markets

Current Ratings

Acura Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 90% 
Equity ratings for Acura Pharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. The company was founded in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals operates under Drug Delivery classification in USA and traded on OTC Market exchange. It employs 15 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAcura Pharmaceuticals Inc
CEO and President and DirectorRobert JonesAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address616 N. North Court
ExchangeOTC Market
CIK Number00786947.0
IndustryPharmaceutical Products
Contact Number847 705 7709
CurrencyUSD - US Dollar


Acura Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
6.0Strong Buy1Odds
Acura Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Acura Pharmaceuticals Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Acura Pharmaceuticals Corporate Directors
George Ross Independent Director
Bruce Wesson Independent Director
Immanuel Thangaraj Independent Director